Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Nephrology

Genetics and Your Family's Risk

At a Glance

Fibronectin glomerulopathy may run in families through a disease-causing FN1 variant, usually with autosomal dominant inheritance. Each child of a carrier has a 50% chance of inheriting it, but symptoms may range from none to kidney failure, so genetic counseling and kidney monitoring are important.

Because Fibronectin glomerulopathy (FNG) can be a hereditary condition, your diagnosis may have implications for your parents, siblings, and children. Understanding the genetics of the disease can help your family members make informed choices about their own health monitoring [1][2].

The FN1 Gene

In a subset of genetically tested FNG cases, a pathogenic variant (a disease-causing mutation) is found in the FN1 gene, which provides the blueprint for making the fibronectin protein [3][1]. These mutations often occur in sections of the gene that help fibronectin stick to other structures in the kidney. When these “binding sites” are broken, the protein clumps together incorrectly [4][5].

If your genetic test does not find an FN1 mutation, it does not necessarily mean you don’t have the disease, nor does it establish that another undiscovered gene is responsible; the case may be sporadic [3][6]. Additionally, a “variant of uncertain significance” (VUS) should not be used to predict disease or guide family testing.

How FNG is Inherited

When FNG is familial, it typically follows an autosomal dominant inheritance pattern [7]. This means:

  • A 50% Chance: If you carry a confirmed pathogenic variant, each of your children has a 50% chance of inheriting that same variant [1].
  • One Copy is Enough: You only need to inherit the mutation from one parent to be at risk for the disease [1].

Reduced Penetrance and Variable Expressivity

One of the most confusing parts of FNG is variable expressivity and reduced penetrance. This means that two people in the same family with the exact same genetic variant can have very different experiences [7].

  • The Asymptomatic Carrier: Some people carry the pathogenic variant but never develop any signs of kidney disease. A normal urine test, eGFR, or blood pressure today does not necessarily exclude a familial variant or future disease [1].
  • Mild vs. Severe Disease: One relative might have only a tiny amount of protein in their urine, while another might develop full nephrotic syndrome or kidney failure [7].

What If No One Else in the Family Is Sick?

It is common for patients to have no known family history of kidney disease. This can happen for several reasons:

  1. De Novo Mutations: Sometimes a mutation happens for the first time in you. These “new” mutations have been documented in both children and adults with FNG [8][9].
  2. Unrecognized Disease: In the past, FNG was often misdiagnosed. A relative might have been told they had “Bright’s disease” or general “kidney inflammation” when they actually had FNG [2].

Screening and Counseling for Your Family

If you have a confirmed genetic mutation, your “first-degree” relatives (parents, siblings, and children) should be informed so they can decide about their own health monitoring. They should be offered referral to a genetic counselor [10].

  • Genetic Counseling: A genetic counselor can help your family understand the risks, reproductive options, privacy considerations, age-appropriate testing for children, and how the results might affect life or disability insurance (legal protections differ by country) [11].
  • Cascade Testing: This is a targeted genetic test for family members to see if they carry the specific pathogenic variant found in you. It is more accurate and often less expensive than a full genetic screen [10].
  • Clinical Screening: For relatives who choose not to have genetic testing, or if no mutation was found in your case, doctors recommend simple clinical checks:
    • Urinalysis: Checking for protein or microscopic blood [12].
    • Blood Pressure: Monitoring for early signs of hypertension [1].
    • eGFR: A blood test to check overall kidney function [12].

By identifying the disease early, doctors can start clinical monitoring in family members [1].

Common questions in this guide

How likely is my child to inherit fibronectin glomerulopathy?
If you have a confirmed disease-causing FN1 variant associated with familial fibronectin glomerulopathy, each child has a 50% chance of inheriting it. Inheriting the variant does not predict exactly whether kidney disease will develop or how severe it will be, because some carriers have no symptoms and others become seriously ill.
Can fibronectin glomerulopathy still be present if my FN1 test is negative?
Yes. FN1 changes are found in only some genetically tested cases, so a negative result does not rule out fibronectin glomerulopathy and does not prove that another gene is responsible. Your care team can use your clinical findings and, when appropriate, urine, blood pressure, and eGFR checks to guide monitoring.
What should I do if my genetic report says VUS?
A variant of uncertain significance (VUS) is a DNA change whose connection to disease is not known. It should not be used to predict fibronectin glomerulopathy or decide that relatives need targeted testing; ask a genetic counselor to help interpret the result.
Should my parents, siblings, or children be tested for FNG?
When a confirmed disease-causing FN1 variant is found, first-degree relatives—parents, siblings, and children—should be informed and offered genetic counseling. They may choose targeted cascade testing for the known variant, or clinical checks such as urine protein, blood pressure, and eGFR if they do not pursue genetic testing or no variant was found.
Can someone have the FN1 variant without kidney symptoms?
Yes. Reduced penetrance means some people with the same disease-causing variant never develop recognizable kidney disease, while variable expressivity means others may have mild protein in the urine, nephrotic syndrome, or kidney failure. A normal urine test, eGFR, or blood pressure reading today does not always exclude a familial variant or future disease.
Why might no one else in my family have fibronectin glomerulopathy?
A new change in the FN1 gene can arise for the first time in an affected person, which is called a de novo variant. Family disease may also go unrecognized because relatives were previously given a nonspecific kidney diagnosis.

Get notified when new evidence is published on Fibronectin glomerulopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    A Novel FN1 Nucleotide Variant c.3051G>C (p.Trp1017Cys) in a Pediatric Patient with Fibronectin Glomerulopathy: Case Report and Literature Review.

    Sun L, Kuang X, Wu Y, Huang W

    Journal of clinical medicine 2026; (15(13)) doi:10.3390/jcm15135016.

    PMID: 42452483
  2. 2

    Fibronectin glomerulopathy in a kidney allograft biopsy.

    Klair N, Mahmood SB, El-Rifai R, et al.

    BMC nephrology 2023; (24(1)):359 doi:10.1186/s12882-023-03403-y.

    PMID: 38053039
  3. 3

    A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family.

    Dos Reis Monteiro MLG, Custódio FB, de Menezes Neves PDM, et al.

    BMC nephrology 2019; (20(1)):322 doi:10.1186/s12882-019-1507-7.

    PMID: 31419955
  4. 4

    Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits.

    Ohtsubo H, Okada T, Nozu K, et al.

    Pediatric nephrology (Berlin, Germany) 2016; (31(9)):1459-67 doi:10.1007/s00467-016-3368-7.

    PMID: 27056061
  5. 5

    Detection of a Splice Site Variant in a Patient with Glomerulopathy and Fibronectin Deposits.

    Tsuji Y, Nozu K, Sofue T, et al.

    Nephron 2018; (138(2)):166-171 doi:10.1159/000484209.

    PMID: 29131116
  6. 6

    Fibronectin glomerulopathy complicated with persistent cloaca and congenital esophageal atresia: a case report and literature review.

    Takii M, Suehiro T, Shima A, et al.

    BMC nephrology 2017; (18(1)):288 doi:10.1186/s12882-017-0704-5.

    PMID: 28877681
  7. 7

    Clinicopathological features of familial fibronectin glomerulopathy caused by a splice site variant in the Fibronectin 1 gene: a case report.

    Nagayama Y, Otani M, Hashimoto M, et al.

    CEN case reports 2025; (14(3)):351-357 doi:10.1007/s13730-025-00987-2.

    PMID: 40120032
  8. 8

    Rapidly progressive pediatric fibronectin glomerulopathy driven by a novel FN1 mutation (p.Thr1917del): implications for early diagnosis and recognition of systemic involvement.

    Chen X, Huang J, Chen Y, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(10)):3409-3422 doi:10.1007/s00467-026-07298-3.

    PMID: 42068364
  9. 9

    A case of unexpected diagnosis of fibronectin glomerulopathy with histological features of membranoproliferative glomerulonephritis.

    Hata M, Mori T, Hirose Y, et al.

    BMC nephrology 2024; (25(1)):25 doi:10.1186/s12882-024-03456-7.

    PMID: 38254040
  10. 10

    Tips for Testing Adults With Suspected Genetic Kidney Disease.

    Savige J

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2024; (83(6)):816-824 doi:10.1053/j.ajkd.2023.10.011.

    PMID: 38147894
  11. 11

    Genetic Counseling in Kidney Disease: A Perspective.

    Stein Q, Westemeyer M, Darwish T, et al.

    Kidney medicine 2023; (5(7)):100668 doi:10.1016/j.xkme.2023.100668.

    PMID: 37334143
  12. 12

    Alport Syndrome Family Screening and Management: Experience of a Tertiary Center.

    Gomes AM, Reis CF, Dias J, et al.

    Kidney medicine 2026; (8(8)):101419 doi:10.1016/j.xkme.2026.101419.

    PMID: 42529192

This page is for informational purposes only and does not constitute medical advice. A nephrologist and genetic counselor can help your family interpret FN1 results and plan appropriate screening.